(via TheNewswire)
![](https://tnw-c.thenewswire.com/data/tnw/clients/logos/BNMFz2mA.png)
![](https://tnw-c.thenewswire.com/data/tnw/img/facebook.png)
![](https://tnw-c.thenewswire.com/data/tnw/img/twitter.png)
![](https://tnw-c.thenewswire.com/data/tnw/img/linkedIn.png)
![](https://tnw-c.thenewswire.com/data/tnw/img/youTube.png)
The name change and updated branding reflects the Company's evolving business strategy and greater focus on new lucrative opportunities in the field of advanced materials. The Company has already developed graphene additives for laminated carbon fiber and fiberglass composites, a fast-growing
The partnership in
Initially, the Company's focus was a specialty market of graphene 3D printing materials, as manifested by its old name "Graphene 3D Lab". Over recent years, the Company has developed a diverse IP portfolio and expertise in the manufacturing of premium-grade graphene materials. The Company has the in-house capacity to create formulations for graphene additives for various materials such as thermoplastics, thermosets such as epoxies, and inks. It allows the Company to tailor graphene properties with a focus on the broad market of industrial composites, making them better, stronger, safer, and lighter.
"We are very excited to present this new image of our Company to our shareholders," commented
ON BEHALF OF THE BOARD:
About
R&D Materials:These diverse materials have a full spectrum of commercial, research, and military applications. The Company's wholly-owned subsidiary,
3D Printing:The 3D printing division of the Company offers a portfolio of 3D printable filaments. These materials can be purchased through multiple distribution networks worldwide or directly from the web-storewww.blackmagic3D.com
High-Performance Epoxies: Adhesive materials produced by the company are distributed under G6-EpoxyTMtrade name and can be purchased atwww.g6-epoxy.com
Fine Organic Chemicals: ChemApproachTM is a worldwide supplier of a wide variety of building blocks to R&D facilities in the pharmaceutical/agricultural industries, biotechnology, academic institutions, and hi-tech companies. Please visithttp://www.chemapproach.com
The Company's headquarters are located at
For More Information:
---------------------------------------------------------------------------- |Commercial Inquiries: | Investor Inquiries: | |Daniel Stolyarov |Telephone: (631) 405-5114 | |Chief Executive Officer |Email:investors@graphene3Dlab.com| |Telephone: (631) 405-5113 | | |Email:daniel.stolyarov@graphene3Dlab.com| | ----------------------------------------------------------------------------
Forward-Looking Statement
This press release may contain forward-looking statements. Forward-looking statements are statements that relate to future, not past, events. In this context, forward-looking statements often address a company's expected future business and financial performance, and often contain words such as "anticipate," "believe," "plan", "estimate", "expect", and "intend", statements that an action or event "may", "might", "could", "should", or "will" be taken or occur, or other similar expressions. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the following risks: the risks associated with outstanding litigation, if any; risks associated with adoption by industries of graphene-based products health and environmental factors affecting adoption of these technologies; reliance on key personnel; the potential for conflicts of interest among certain officers, directors or promoters with certain other projects; the absence of dividends; competition; dilution; the volatility of our common share price and volume; and tax consequences to
Copyright (c) 2020 TheNewswire - All rights reserved.
Copyright (c) 2020 TheNewswire - All rights reserved., source